fda compounding glp-1 enforcement news november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our 🚨 FDA Moves to Permanently

But be direct: depending on your medication and pharmacy, the list price can still add variability, especially on higher doses

In recent years, GLP-1 medications dramatically changed obesity medicine

PMC 10378459

Keep in mind that a component discussion does not replace product-specific labeling or your prescribers assessment

As these medications slow digestion and support long lasting fullness, it is completely normal to experience early symptoms while your body adjusts

Molecular metabolism 1(50):101115 Liu Z, Zhang Y, Graham S, Wang X, Cai D, Huang M, Pique-Regi R, Dong XC, Chen YE, Willer C, Liu W (2020) Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping